PDCD1 and glioblastoma: The count of PD-1+lymphocytes and the percentage of PD-1+CD8+T cells are negative prognostic indicators for overall survival and progression-free survival among glioblastoma patients received autologous DCs but not in the control group, suggesting that PD-1+T cells infiltrating might be a biomarker for DC treatment (88).